Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats

Neuroscience

Volumn 300, Issue , 2015, Pages 593-608

  Kovacs Z ^a   Kekesi K A ^b   Dobolyi, A ^c,d   Lakatos, R ^a   Juhasz G ^b,c  

^a UNIVERSITY OF WEST HUNGARY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Absence epilepsy; Guanosine; Inosine; Uridine; WAG Rij rats

Indexed keywords

BICUCULLINE; DIZOCILPINE; GUANOSINE; INOSINE; MUSCIMOL; THEOPHYLLINE; URIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE RECEPTOR; ANTICONVULSIVE AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP WAKING CYCLE; SPIKE WAVE; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; ELECTROCORTICOGRAPHY; EPILEPSY, ABSENCE; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCORTICOGRAPHY; EPILEPSY, ABSENCE; GUANOSINE; INOSINE; MALE; RATS, WISTAR; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, PURINERGIC P1; URIDINE;

EID: 84931266823     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.05.054     Document Type: Article

References (77)

1. Ates N., Sahin D., Ilbay G. Theophylline, a methylxanthine derivative, suppresses absence epileptic seizures in WAG/Rij rats. Epilepsy Behav 2004, 5(5):645-648.
2. Boison D. Modulators of nucleoside metabolism in the therapy of brain diseases. Curr Top Med Chem 2011, 11(8):1068-1086.
3. Brunschweiger A., Muller C.E. P2 receptors activated by uracil nucleotides-an update. Curr Med Chem 2006, 13(3):289-312.
4. Burnstock G., Fredholm B.B., Verkhratsky A. Adenosine and ATP receptors in the brain. Curr Top Med Chem 2011, 11(8):973-1011.
5. Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res Rev 2006, 52(2):389-397.
6. Ciccarelli R., Di Iorio P., D'Alimonte I., Giuliani P., Florio T., Caciagli F., Middlemiss P.J., Rathbone M.P. Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Glia 2000, 29(3):202-211.
7. Coenen A.M., Van Luijtelaar E.L. Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behav Genet 2003, 33(6):635-655.
8. Coenen A.M., Drinkenburg W.H., Peeters B.W., Vossen J.M., Van Luijtelaar E.L. Absence epilepsy and the level of vigilance in rats of the WAG/Rij strain. Neurosci Biobehav Rev 1991, 15(2):259-263.
9. Coenen A.M., Blezer E.H., Van Luijtelaar E.L. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Epilepsy Res 1995, 21(2):89-94.
10. Cope D.W., Di Giovanni G., Fyson S.J., Orbán G., Errington A.C., Lorincz M.L., Gould T.M., Carter D.A., Crunelli V. Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat Med 2009, 15(12):1392-1398.
11. Crunelli V, Leresche N, Cope DW (2012) GABA-A receptor function in typical absence seizures. In: Jasper's Basic Mechanisms of the Epilepsies [Internet] (Noebels JL, Avoli M, Rogawski MA, et al., eds), 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); . http://www.ncbi.nlm.nih.gov/books/NBK98213/.
12. D'Alimonte I., D'Auro M., Citraro R., Biagioni F., Jiang S., Nargi E., Buccella S., Di Iorio P., Giuliani P., Ballerini P., Caciagli F., Russo E., De Sarro G., Ciccarelli R. Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease. Eur J Neurosci 2009, 30(6):1023-1035.
13. De Oliveira D.L., Horn J.F., Rodrigues J.M., Frizzo M.E., Moriguchi E., Souza D.O., Wofchuk S. Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine. Brain Res 2004, 1018(1):48-54.
14. Depaulis A, Van Luijtelaar G (2005) Genetic models of absence epilepsy in the rat. In: Models of seizures and epilepsy, Chapter 18 (Pitkänen A, Schwartzkroin PA, Moshé SL, eds), pp 233-248. Academic Press.
15. Di Iorio P., Ballerini P., Traversa U., Nicoletti F., D'Alimonte I., Kleywegt S., Werstiuk E.S., Rathbone M.P., Caciagli F., Ciccarelli R. The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. Glia 2004, 46(4):356-368.
16. Dobolyi Á., Szikra T., Kékesi A.K., Kovács Z., Juhász G. Uridine is released by depolarization and inhibits unit activity in the rat hippocampus. Neuroreport 1999, 10(14):3049-3053.
17. Drinkenburg W.H., Coenen A.M., Vossen J.M., Van Luijtelaar E.L. Spike-wave discharges and sleep-wake states in rats with absence epilepsy. Epilepsy Res 1991, 9(3):218-224.
18. Filakovszky J., Kantor S., Halasz P., Bagdy G. 8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance. Neurochem Int 2001, 38(7):551-556.
19. Fredholm B.B., Vernet L. Release of 3H-nucleosides from 3H-adenine labelled hypothalamic synaptosomes. Acta Physiol Scand 1979, 106(2):97-107.
20. Frizzo M.E., Antunes Soares F.A., Dall'Onder L.P., Lara D.R., Swanson R.A., Souza D.O. Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res 2003, 972(1-2):84-89.
21. Ganzella M., Faraco R.B., Almeida R.F., Fernandes V.F., Souza D.O. Intracerebroventricular administration of inosine is anticonvulsant against quinolinic acid-induced seizures in mice: an effect independent of benzodiazepine and adenosine receptors. Pharmacol Biochem Behav 2011, 100(2):271-274.
22. Giuliani P., Ballerini P., Ciccarelli R., Buccella S., Romano S., D'Alimonte I., Poli A., Beraudi A., Peña E., Jiang S., Rathbone M.P., Caciagli F., Di Iorio P. Tissue distribution and metabolism of guanosine in rats following intraperitoneal injection. J Biol Regul Homeost Agents 2012, 26(1):51-65.
23. Guarneri P., Guarneri R., La Bella V., Piccoli F. Interaction between uridine and GABA-mediated inhibitory transmission: studies in vivo and in vitro. Epilepsia 1985, 26(6):666-671.
24. Haskó G., Sitkovsky M.V., Cs Szabó. Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 2004, 25(3):152-157.
25. Honda K., Okano Y., Komoda Y., Inoué S. Sleep-promoting effects of intraperitoneally administered uridine in unrestrained rats. Neurosci Lett 1985, 62(1):137-141.
26. Ilbay G., Sahin D., Karson A., Ates N. Effects of adenosine administration on spike-wave discharge frequency in genetically epileptic rats. Clin Exp Pharmacol Physiol 2001, 28(8):643-646.
27. Ipata P.L. Origin, utilization, and recycling of nucleosides in the central nervous system. Adv Physiol Educ 2011, 35(4):342-346.
28. Ipata P.L., Balestri F. The regulation of brain nucleoside utilization. Curr Metabolomics 2014, 2(2):144-154.
29. Johansson B., Fredholm B.B. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography. Neuropharmacology 1995, 34(4):393-403.
30. Kimura T., Ho I.K., Yamamoto I. Uridine receptor: discovery and its involvement in sleep mechanism. Sleep 2001, 24(3):251-260.
31. Kimura T., Miki M., Ikeda M., Yonemoto S., Watanabe K., Kondo S., Ho I.K., Yamamoto I. Possible existence of a novel receptor for uridine analogues in the central nervous system using two isomers, N3-(S)-(+)- and N3-(R)-(-)-alpha-hydroxy-beta-phenethyluridines. Biol Pharm Bull 2001, 24(6):729-731.
32. Koerner C., Danober L., Boehrer A., Marescaux C., Vergnes M. Thalamic NMDA transmission in a genetic model of absence epilepsy in rats. Epilepsy Res 1996, 25(1):11-19.
33. Kovács Z., Dobolyi A. Anatomical distribution of nucleoside system in the human brain and implications for therapy. Adenosine: a key link between metabolism and brain activity 2013, 621-656. Business Media, New York, Springer Science. S.A. Masino, D. Boison (Eds.).
34. Kovács Z., Kékesi K.A., Szilágyi N., Ábrahám I., Székács D., Király N., Papp E., Császár I., Szego É., Barabás K., Péterfy H., Erdei A., Bártfai T., Juhász G. Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats. Neuroscience 2006, 140(2):731-742.
35. Kovács Z., Dobolyi A., Juhász G., Kékesi K.A. Nucleoside map of the human central nervous system. Neurochem Res 2010, 35(3):452-464.
36. Kovács Z., Juhász G., Palkovits M., Dobolyi A., Kékesi K.A. Area, age and gender dependence of the nucleoside system in the brain: a review of current literature. Curr Top Med Chem 2011, 11(8):1012-1033.
37. Kovács Z., Dobolyi Á., Kékesi A., Juhász G. 5'-nucleotidases, nucleosides and their distribution in the brain: pathological and therapeutic implications. Curr Med Chem 2013, 20(34):4217-4240.
38. Kovács Z., Slézia A., Bali Z.K., Kovács P., Dobolyi A., Szikra T., Hernádi I., Juhász G. Uridine modulates neuronal activity and inhibits spike-wave discharges of absence epileptic Long Evans and Wistar Albino Glaxo/Rijswijk rats. Brain Res Bull 2013, 97:16-23.
39. Kovács Z., Kékesi K.A., Juhász G., Dobolyi A. The antiepileptic potential of nucleosides. Curr Med Chem 2014, 21(6):788-821.
40. Kovács Z., Kékesi K.A., Juhász G., Barna J., Héja L., Lakatos R., Dobolyi A. Non-adenosine nucleoside inosine, guanosine and uridine as promising antiepileptic drugs: a summary of current literature. Mini Rev Med Chem 2015, 14(13):1033-1042.
41. Krooth R.S., Hsiao W.L., Lam G.F. Effects of natural pyrimidines and of certain related compounds on the spontaneous activity of the mouse. J Pharmacol Exp Ther 1978, 207(2):504-514.
42. Lara D.R., Schmidt A.P., Frizzo M.E., Burgos J.S., Ramírez G., Souza D.O. Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res 2001, 912(2):176-180.
43. Lewin E., Bleck V. Effect of inosine on seizures induced with pentylenetetrazole, bicuculline, or picrotoxin. Epilepsia 1985, 26(3):258-261.
44. Liu Z., Vergnes M., Depaulis A., Marescaux C. Involvement of intrathalamic GABAB neurotransmission in the control of absence seizures in the rat. Neuroscience 1992, 48(1):87-93.
45. Lüttjohann A., Zhang S., de Peijper R., van Luijtelaar G. Electrical stimulation of the epileptic focus in absence epileptic WAG/Rij rats: assessment of local and network excitability. Neuroscience 2011, 188:125-134.
46. Marangos P.J., Martino A.M., Paul S.M., Skolnick P. The benzodiazepines and inosine antagonize caffeine-induced seizures. Psychopharmacology 1981, 72(3):269-273.
47. Masino S.A., Kawamura M., Ruskin D.N., Geiger J.D., Boison D. Purines and neuronal excitability: links to the ketogenic diet. Epilepsy Res 2012, 100(3):229-238.
48. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998, 281(5381):1349-1352.
49. Paas Y., Devillers-Thiéry A., Changeux J.P., Medevielle F., Teichberg V.I. Identification of an extracellular motif involved in the binding of guanine nucleotides by a glutamate receptor. EMBO J 1996, 15(7):1548-1556.
50. The rat brain stereotaxic coordinates 1999, Academic Press, Orlando. G. Paxinos, C. Watson (Eds.).
51. Peeters B.W., Van Rijn C.M., Vossen J.M., Coenen A.M. Effects of GABA-ergic agents on spontaneous non-convulsive epilepsy, EEG and behaviour, in the WAG/RIJ inbred strain of rats. Life Sci 1989, 45(13):1171-1176.
52. Pisu M.G., Mostallino M.C., Dore R., Mura M.L., Maciocco E., Russo E., De Sarro G., Serra M. Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy. J Neurochem 2008, 106(6):2502-2514.
53. Pooler A.M., Guez D.H., Benedictus R., Wurtman R.J. Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells. Neuroscience 2005, 134(1):207-214.
54. Porciúncula L.O., Vinadé L., Wofchuk S., Souza D.O. Guanine based purines inhibit [(3)H]glutamate and [(3)H]AMPA binding at postsynaptic densities from cerebral cortex of rats. Brain Res 2002, 928(1-2):106-112.
55. Rathbone M.P., Middlemiss P.J., DeLuca B., Jovetich M. Extracellular guanosine increases astrocyte cAMP: inhibition by adenosine A2 antagonists. Neuroreport 1991, 2(11):661-664.
56. Roberts C.A. Anticonvulsant effects of uridine: comparative analysis of metrazol and penicillin induced foci. Brain Res 1973, 55(2):291-308.
57. Sakamoto T., Cansev M., Wurtman R.J. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 2007, 1182:50-59.
58. Schmidt A.P., Lara D.R., De Faria Maraschin J., Da Silveira Perla A., Onofre Souza D. Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res 2000, 864(1):40-43.
59. Schmidt A.P., Avila T.T., Souza D.O. Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice. Neurochem Res 2005, 30(1):69-73.
60. Schmidt A.P., Lara D.R., Souza D.O. Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther 2007, 116(3):401-416.
61. Schmidt A.P., Paniz L., Schallenberger C., Böhmer A.E., Wofchuk S.T., Elisabetsky E., Portela L.V., Souza D.O. Guanosine prevents thermal hyperalgesia in a rat model of peripheral mononeuropathy. J Pain 2010, 11(2):131-141.
62. Sherman S.M. Tonic and burst firing: dual modes of thalamocortical relay. Trends Neurosci 2001, 24(2):122-126.
63. Skolnick P., Syapin P.J., Paugh B.A., Moncada V., Marangos P.J., Paul S.M. Inosine, an endogenous ligand of the brain benzodiazepine receptor, antagonizes pentylenetetrazole-evoked seizures. Proc Natl Acad Sci U S A 1979, 76(3):1515-1518.
64. Slézia A., Kékesi A.K., Szikra T., Papp A.M., Nagy K., Szente M., Maglóczky Z., Freund T.F., Juhász G. Uridine release during aminopyridine-induced epilepsy. Neurobiol Dis 2004, 16(3):490-499.
65. Snead O.C. Basic mechanisms of generalized absence seizures. Ann Neurol 1995, 37(2):146-157.
66. Soares F.A., Schmidt A.P., Farina M., Frizzo M.E., Tavares R.G., Portela L.V., Lara D.R., Souza D.O. Anticonvulsant effect of GMP depends on its conversion to guanosine. Brain Res 2004, 1005(1-2):182-186.
67. Tavares R.G., Schmidt A.P., Tasca C.I., Souza D.O. Quinolinic acid-induced seizures stimulate glutamate uptake into synaptic vesicles from rat brain: effects prevented by guanine-based purines. Neurochem Res 2008, 33(1):97-102.
68. Torres F.V., da Silva Filho M., Antunes C., Kalinine E., Antoniolli E., Portela L.V., Souza D.O., Tort A.B. Electrophysiological effects of guanosine and MK-801 in a quinolinic acid-induced seizure model. Exp Neurol 2010, 221(2):296-306.
69. Traversa U., Bombi G., Camaioni E., Macchiarulo A., Costantino G., Palmieri C., Caciagli F., Pellicciari R. Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorg Med Chem 2003, 11(24):5417-5425.
70. Van Luijtelaar G., Sitnikova E., Littjohann A. On the origin and suddenness of absences in genetic absence models. Clin EEG Neurosci 2011, 42(2):83-97.
71. Vinadé E.R., Schmidt A.P., Frizzo M.E., Izquierdo I., Elisabetsky E., Souza D.O. Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res 2003, 977(1):97-102.
72. Volpini R., Marucci G., Buccioni M., Dal Ben D., Lambertucci C., Lammi C., Mishra R.C., Thomas A., Cristalli G. Evidence for the existence of a specific g protein-coupled receptor activated by guanosine. ChemMedChem 2011, 6(6):1074-1080.
73. Wurtman R.J. A nutrient combination that can affect synapse formation. Nutrients 2014, 6(4):1701-1710.
74. Wurtman R.J., Cansev M., Ulus I.H. Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides. J Nutr Health Aging 2009, 13(3):189-197.
75. Zhao Q., Marolewski A., Rusche J.R., Holmes G.L. Effects of uridine in models of epileptogenesis and seizures. Epilepsy Res 2006, 70(1):73-82.
76. Zhao Q., Shatskikh T., Marolewski A., Rusche J.R., Holmes G.L. Effects of uridine on kindling. Epilepsy Behav 2008, 13(1):47-51.
77. Zimmermann H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 1996, 49(6):589-618.